This appointment acknowledges Dr. Llàcer's work in the comprehensive care of patients with heart failure, a complex condition with high comorbidity rates. The Heart Failure Association (HFA), a leading international scientific organization, aims through its scientific committees to promote research and training initiatives to advance the understanding and management of this disease.
The nomination was put forward by Professor Wilfried Mullens, president of the HFA for the 2026-2028 period. Dr. Luis Manzano, head of the Internal Medicine Department at the hospital, expressed pride in Dr. Llàcer's clinical and research contributions since joining in 2020, noting that this recognition validates the efforts made across Spain through programs like UMIPIC, which originated at Ramón y Cajal.
This development highlights the growing influence of Spanish Internal Medicine in European scientific structures. It reinforces the internist's role in managing highly complex patients, who constitute a significant portion of users within the National Health System. The hospital's involvement in international scientific and collaborative initiatives driven by the HFA is expected to be enhanced.
Heart failure currently presents a major socio-sanitary challenge, exacerbated by an aging population. It is the most diagnosed pathology among individuals over 70, the leading cause of hospitalization in this age group, and the third cause of cardiovascular death. Patients with heart failure often have multiple co-existing medical issues, including respiratory, renal, hematological, and psychological conditions, alongside cardiovascular disease.
